5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide and tak 044

5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide has been researched along with tak 044 in 2 studies

Compound Research Comparison

Studies (5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide)	Trials (5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide)	Recent Studies (post-2010) (5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide)	Studies (tak 044)	Trials (tak 044)	Recent Studies (post-2010) (tak 044)
73	0	8	105	8	2

Protein Interaction Comparison

Protein	Taxonomy	5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide (IC50)	tak 044 (IC50)
Endothelin-1 receptor	Homo sapiens (human)		0.0002

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hirata, Y; Sugiyama, T	1
Briyal, S; Gulati, A; Philip, T	1

Reviews

1 review(s) available for 5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide and tak 044

Article	Year
[Endothelin-1 and arteriosclerosis]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 9 Topics: Animals; Arteriosclerosis; Cell Division; Dansyl Compounds; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Humans; Muscle, Smooth, Vascular; Neovascularization, Pathologic; Peptides, Cyclic; Receptor, Endothelin A; Receptor, Endothelin B; Vasoconstriction	2004

Article

Year

[Endothelin-1 and arteriosclerosis].

Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 9

Topics: Animals; Arteriosclerosis; Cell Division; Dansyl Compounds; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Humans; Muscle, Smooth, Vascular; Neovascularization, Pathologic; Peptides, Cyclic; Receptor, Endothelin A; Receptor, Endothelin B; Vasoconstriction

2004

Other Studies

1 other study(ies) available for 5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide and tak 044

Article	Year
Endothelin-A receptor antagonists prevent amyloid-β-induced increase in ETA receptor expression, oxidative stress, and cognitive impairment. Journal of Alzheimer's disease : JAD, 2011, Volume: 23, Issue:3 Topics: Amyloid beta-Peptides; Animals; Cognition Disorders; Dansyl Compounds; Endothelin A Receptor Antagonists; Gene Expression Regulation; Male; Oxidative Stress; Peptide Fragments; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A	2011

Article

Year

Endothelin-A receptor antagonists prevent amyloid-β-induced increase in ETA receptor expression, oxidative stress, and cognitive impairment.

Journal of Alzheimer's disease : JAD, 2011, Volume: 23, Issue:3

Topics: Amyloid beta-Peptides; Animals; Cognition Disorders; Dansyl Compounds; Endothelin A Receptor Antagonists; Gene Expression Regulation; Male; Oxidative Stress; Peptide Fragments; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A

2011